High-Flow Nasal Cannula Market Size and Growth
The high-flow nasal cannula market is anticipated to showcase a robust CAGR of 11.8% during the forecast period (2020-2025). Technological advancements by key market players are also anticipated to burgeon the high-flow nasal cannula market. Moreover, clinical trials for evaluating new application areas shall open up new avenues for the market. According to the Global Burden of Disease Study, 2013, around 300 million people suffered from COPD during that year. This is attributed to growing addiction for smoking, deteriorating air quality and rising pollution across the globe. The prevalence of respiratory disorders will further boost market prospects.
Acute Respiratory Failures to Remain Dominant, Sleep Apnea to Expand Healthily
Acute respiratory failures are anticipated to find widespread application of high-flow oxygen therapy using high-flow nasal cannula market. The unique advantages of high-flow nasal cannula and the growing acceptance of this method amongst these patients are anticipated to bolster market share. The Acute Respiratory Failures segment shall account for around three-tenth of the high-flow nasal cannula market, growing impressively at a CAGR of 11.4%.
Following the Acute Respiratory Failures segment is the Sleep Apnea segment. High-flow nasal cannula devices help in this regard by delivering a consistent flow of oxygen via the nasal cannula and alleviate upper airway obstruction. Rising prevalence of sleep apnea is also anticipated to boost the market of high-flow nasal cannula. Projected CAGR is pegged at 13.5% throughout the forecast period.
To get detailed regional insights on the high-flow nasal cannula market, ask an analyst here
High-Flow Nasal Cannula Regional Insights
North America is anticipated to dominate the high-flow nasal cannula market during the forecast period. Preference for non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) devices has augmented rapidly in home care settings for patients suffering from respiratory diseases in North America. This has stimulated key manufacturers to increase production of high-flow nasal cannula devices, thus increasing the market share. The North American high-flow nasal cannula market share is projected to be more than two-fifth.
Asia-Pacific shows impressive growth prospects for the high-flow nasal cannula market during the forecast period. The Asia-Pacific region is anticipated to expand at a CAGR of 13.2%, capturing a market share of almost one-fifth of the total high-flow nasal cannula market. Increasing population, degraded air quality and growing smoking prevalence have increased the number of respiratory disease cases. This has augmented the market for high-flow nasal cannula market in Asia-Pacific.
Get the latest COVID-19 impact insights on the high-flow nasal cannula market by requesting for a report sample here
High-Flow Nasal Cannula Market Manufacturers’ Strategies
The global high-flow nasal cannula market is fragmented. Out of the existing players, four of them account for three-tenth of the market share. These companies are Fisher & Paykel Healthcare Limited, BD/CareFusion, ResMed Inc., and Telefax incorporated. These players are consistently innovating their product portfolios by virtue of technological advancements to acquire market presence.
Fisher & Paykel is a leading players in the global high-flow nasal cannula market. Its flagship products include F&P 950 Humidifier, Optiflow High-flow System and the AIRVO 2. Other products include OptiFlowTM Nasal High, F&P Brevida Masks and the F&P SimplusTM Full Face Masks.
ResMed, Inc. is another market leader in the respiratory therapy market. It offers a strong product portfolio for the treatment of sleep apnea and non-invasive ventilation. Its flagship products include AirView, myAir and ClimateLine MAX for the treatment and management of sleep apnea and respiratory disorders.
COVID-19’s Impact on the High-flow Nasal Cannula Market:
The COVID-19 pandemic has heightened the market prospects for high-flow nasal cannula market. Owing to its widespread application in the treatment of various respiratory diseases, high-flow nasal cannula is anticipated to ease the complications faced by COVID-19 affected patients. Since the disease primarily affects the lungs, HFNC is a suitable approach to help patients breathe normally by providing free flowing oxygen.
The HFNC technique scores over conventional oxygen therapy as it can tolerate deficiencies of unheated and non-humidified oxygen. It can regulate the temperature and moisture levels to provide greater comfort to infected patients. Leading players in the high-flow nasal cannula market are also contributing effectively towards the mitigation of the pandemic. For instance, Fisher & Paykel is accelerating its production of ventilators and other respiratory support and humidification products to hospitals. Likewise, ResMed has accelerated its production of its AirCurve 10 bi-level devices to provide some comfort to COVID-19 patients.
Analyst’s Viewpoint:
“Rising incidence of respiratory problems is anticipated to steer the high-flow nasal cannula market towards a positive growth trajectory. Moreover, the coronavirus pandemic is anticipated to leverage market prospects, owing to its suitability in oxygen delivery to patients.”
High-flow Nasal Cannula Market: Report Scope:
The recent report compiled by Fact.MR on the high-flow nasal cannula market incorporates a 5-year forecast from 2020 to 2025 and includes analysis on vital dynamics such as the key drivers, opportunities and restraints. A detailed analysis on the revenue, market share and yearly growth prospects have been provided based on the following segments: component, application and end-user.
A regional landscape incorporates the abovementioned segmental analyses as well. The regional landscape is based on the following geographies: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Towards the end of the report, a competition landscape has been mapped, providing information on the key market players, their expansion strategies, revenues and market shares and product portfolios. A SWOT analysis has also been provided for each player in order to present a realistic scenario.
High-flow Nasal Cannula Market- Scope of the Report
The recent study by Fact.MR on high-flow nasal cannula market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the high-flow nasal cannula market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the development of high-flow nasal cannula devices. The study also provides dynamics that are responsible for influencing the future status of the high-flow nasal cannula market over the forecast period.
A detailed assessment of the high-flow nasal cannula market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the high-flow nasal cannula market along with their product portfolio enhances the reliability of this comprehensive research study.
High-flow Nasal Cannula Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the High-flow Nasal Cannula market across the globe.
A comprehensive estimate on the high-flow nasal cannula market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of high-flow nasal cannula devices during the forecast period. Price point comparison by region with global average price is also considered in the study.
High-flow Nasal Cannula Market Segmentation
Fact.MR has studied the high-flow nasal cannula market with detailed segmentation on the basis of component, application, end-user and key regions.
|
Component |
Application |
End-user |
Key Regions |
|
Air/Oxygen Blend |
Acute Respiratory Failure |
Hospitals |
North America |
|
Air Humidifier |
Chronic Obstructive Pulmonary Disease (COPD) |
Long-term Care Centers |
Europe |
|
Single Heated Tube |
Carbon Monoxide Toxicity |
Ambulatory Care Centers |
Asia Pacific |
|
Nasal Cannula |
Bronchiectasis |
Tomosynthesis |
Latin America |
|
Other Consumables |
Sleep Apnea |
Other End-users |
Middle East & Africa |
|
|
Acute Respiratory Failure |
|
|
|
|
Other Applications |
|
|
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
High-flow Nasal Cannula market: Analysis on Market Size Evaluation
The High-flow Nasal Cannula market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for high-flow nasal cannula is available in terms of “US$ Mn” for value, along with market attractiveness evaluation in the report. A Y-o-Y growth contrast on prominent glaucoma therapeutic segments, along with market attractiveness evaluation has been incorporated in the report.
High-flow Nasal Cannula Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the high-flow nasal cannula market report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of high-flow nasal cannula market during the forecast period.
Country-specific valuation on demand for high-flow nasal cannula devices has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. Detailed breakup in terms of value for emerging countries has also been included in the report.
High-flow Nasal Cannula Market: In-Depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of high-flow nasal cannula devices along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of high-flow nasal cannula devices, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in High-flow Nasal Cannula market. Prominent manufacturers with established market presence in the high-flow nasal cannula market are Fisher & Paykel Healthcare Limited, Vapotherm Ltd., ResMed Ltd. and Becton, Dickinson and Company, to name a few.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global High-flow Nasal Cannula Market Size (US$ Mn) and Forecast, by Region, 2020 and 2025
3.2. Global High-flow Nasal Cannula Market: Market Snapshot
4. Market Overview
4.1. Global High-flow Nasal Cannula Market Overview
4.2. Global High-flow Nasal Cannula Market Key Industry Developments
4.3. Key Industry Events
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends
5.6. Global High-flow Nasal Cannula Market Revenue Projections (US$ Mn), 2020–2025
5.7. High-flow Nasal Cannula Market: Mergers & Acquisitions
5.8. Heat Map Analysis - Company
6. Global High-flow Nasal Cannula Market Analysis, by Component
6.1. Introduction
6.2. Key Insights
6.3. Global High-flow Nasal Cannula Market Size and Forecast, by Component
6.3.1. Air/Oxygen Blend
6.3.2. Air Humidifier
6.3.3. Single Heated Tube
6.3.4. Nasal Cannula
6.3.5. Other Consumables
6.4. Global High-flow Nasal Cannula Market Analysis, by Component
6.5. Global High-flow Nasal Cannula Market Attractiveness Analysis, by Component
7. Global High-flow Nasal Cannula Market Analysis, by End User
7.1. Introduction
7.2. Key Insights
7.3. Global High-flow Nasal Cannula Market Size and Forecast, by End User
7.3.1. Hospitals
7.3.2. Long-term Care Centers
7.3.3. Ambulatory Care Centers
7.3.4. Tomosynthesis
7.3.5. Others End User
7.4. Global High-flow Nasal Cannula Market Analysis, by End User
7.5. Global High-flow Nasal Cannula Market Attractiveness Analysis, by End User
8. Global High-flow Nasal Cannula Market Analysis, by Applications
8.1. Introduction
8.2. Key Insights
8.3. Global High-flow Nasal Cannula Market Size and Forecast, by Applications
8.3.1. Acute Respiratory Failure
8.3.2. Chronic Obstructive Pulmonary Disease (COPD)
8.3.3. Carbon Monoxide Toxicity
8.3.4. Bronchiectasis
8.3.5. Sleep Apnea
8.3.6. Acute Respiratory Failure
8.3.7. Other Applications
8.4. Global High-flow Nasal Cannula Market Analysis, by Applications
8.5. Global High-flow Nasal Cannula Market Attractiveness Analysis, by Applications
9. Global High-flow Nasal Cannula Market Analysis, by Region
9.1. Introduction
9.2. Key Insights
9.3. Global High-flow Nasal Cannula Market Size and Forecast , by Region, 2020–2025
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global High-flow Nasal Cannula Market Analysis, by Region
9.5. Global High-flow Nasal Cannula Market Attractiveness Analysis, by Region
10. North America High-flow Nasal Cannula Market Analysis
10.1. North America High-flow Nasal Cannula Market Key Findings
10.2. North America High-flow Nasal Cannula Market Overview
10.3. North America High-flow Nasal Cannula Market Size and Forecast, by Component
10.3.1. Air/Oxygen Blend
10.3.2. Air Humidifier
10.3.3. Single Heated Tube
10.3.4. Nasal Cannula
10.3.5. Other Consumables
10.3.6. North America High-flow Nasal Cannula Market Analysis, by Component
10.4. North America High-flow Nasal Cannula Market Size and Forecast, by End User
10.4.1. Hospital Based Laboratories
10.4.2. Diagnostic laboratories
10.4.3. Specialty Clinics
10.4.4. Others
10.5. North America High-flow Nasal Cannula Market Forecast, by Applications
10.5.1. Acute Respiratory Failure
10.5.2. Chronic Obstructive Pulmonary Disease (COPD)
10.5.3. Carbon Monoxide Toxicity
10.5.4. Bronchiectasis
10.5.5. Sleep Apnea
10.5.6. Acute Respiratory Failure
10.5.7. Other Applications
10.6. North America High-flow Nasal Cannula Market Forecast, by Country
10.6.1. U.S.
10.6.2. Canada
10.7. North America High-flow Nasal Cannula Market Attractiveness Analysis
10.7.1. By Component
10.7.2. By End User
10.7.3. By Applications
10.7.4. By Country
11. Europe High-flow Nasal Cannula Market Analysis
11.1. Europe High-flow Nasal Cannula Market Key Findings
11.2. Europe High-flow Nasal Cannula Market Overview
11.3. Europe High-flow Nasal Cannula Market Size and Forecast, by Component
11.3.1. Air/Oxygen Blend
11.3.2. Air Humidifier
11.3.3. Single Heated Tube
11.3.4. Nasal Cannula
11.3.5. Other Consumables
11.4. Europe High-flow Nasal Cannula Market Size and Forecast, by End User
11.4.1. Hospitals
11.4.2. Long-term Care Centers
11.4.3. Ambulatory Care Centers
11.4.4. Tomosynthesis
11.4.5. Others End User
11.5. Europe High-flow Nasal Cannula Market Forecast, by Applications
11.5.1. Acute Respiratory Failure
11.5.2. Chronic Obstructive Pulmonary Disease (COPD)
11.5.3. Carbon Monoxide Toxicity
11.5.4. Bronchiectasis
11.5.5. Sleep Apnea
11.5.6. Acute Respiratory Failure
11.5.7. Other Applications
11.6. Europe High-flow Nasal Cannula Market Forecast, by Country
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Spain
11.6.5. Italy
11.6.6. Rest of Europe
11.7. Europe High-flow Nasal Cannula Market Attractiveness Analysis
11.7.1. By Component
11.7.2. By End User
11.7.3. By Applications
11.7.4. By Country
12. Asia Pacific High-flow Nasal Cannula Market Analysis
12.1. Asia Pacific High-flow Nasal Cannula Market Key Findings
12.2. Asia Pacific High-flow Nasal Cannula Market Overview
12.3. Asia Pacific Cytometry Market Size and Forecast, by Component
12.3.1. Air/Oxygen Blend
12.3.2. Air Humidifier
12.3.3. Single Heated Tube
12.3.4. Nasal Cannula
12.3.5. Other Consumables
12.4. Asia Pacific High-flow Nasal Cannula Market Size and Forecast, by End User
12.4.1. Hospitals
12.4.2. Long-term Care Centers
12.4.3. Ambulatory Care Centers
12.4.4. Tomosynthesis
12.4.5. Others End User
12.5. Asia Pacific High-flow Nasal Cannula Market Forecast, by Applications
12.5.1. Acute Respiratory Failure
12.5.2. Chronic Obstructive Pulmonary Disease (COPD)
12.5.3. Carbon Monoxide Toxicity
12.5.4. Bronchiectasis
12.5.5. Sleep Apnea
12.5.6. Acute Respiratory Failure
12.5.7. Other Applications
12.6. Asia Pacific High-flow Nasal Cannula Market Forecast, by Country
12.6.1. China
12.6.2. India
12.6.3. Japan
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Asia Pacific High-flow Nasal Cannula Market Attractiveness Analysis
12.7.1. By Component
12.7.2. By End User
12.7.3. By Applications
12.7.4. By Country
13. Latin America High-flow Nasal Cannula Market Analysis
13.1. Latin America High-flow Nasal Cannula Market Key Findings
13.2. Latin America High-flow Nasal Cannula Market Overview
13.3. Latin America Cytometry Market Size and Forecast, by Component
13.3.1. Air/Oxygen Blend
13.3.2. Air Humidifier
13.3.3. Single Heated Tube
13.3.4. Nasal Cannula
13.3.5. Other Consumables
13.4. Latin America High-flow Nasal Cannula Market Size and Forecast, by End User
13.4.1. Hospitals
13.4.2. Long-term Care Centers
13.4.3. Ambulatory Care Centers
13.4.4. Tomosynthesis
13.4.5. Others End User
13.5. Latin America High-flow Nasal Cannula Market Forecast, by Country
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America High-flow Nasal Cannula Market Forecast, by Applications
13.6.1. Acute Respiratory Failure
13.6.2. Chronic Obstructive Pulmonary Disease (COPD)
13.6.3. Carbon Monoxide Toxicity
13.6.4. Bronchiectasis
13.6.5. Sleep Apnea
13.6.6. Acute Respiratory Failure
13.6.7. Other Applications
13.7. Latin America High-flow Nasal Cannula Market Attractiveness Analysis
13.7.1. By Component
13.7.2. By End User
13.7.3. By Applications
13.7.4. By Country
14. Middle East & Africa High-flow Nasal Cannula Market Analysis
14.1. Middle East & Africa High-flow Nasal Cannula Market Key Findings
14.2. Middle East & Africa High-flow Nasal Cannula Market Overview
14.3. Middle East & Africa Cytometry Market Size and Forecast, by Component
14.3.1. Air/Oxygen Blend
14.3.2. Air Humidifier
14.3.3. Single Heated Tube
14.3.4. Nasal Cannula
14.3.5. Other Consumables
14.4. Middle East & Africa High-flow Nasal Cannula Market Size and Forecast, by End User
14.4.1. Hospitals
14.4.2. Long-term Care Centers
14.4.3. Ambulatory Care Centers
14.4.4. Tomosynthesis
14.4.5. Others End User
14.5. Middle East & Africa High-flow Nasal Cannula Market Forecast, by Applications
14.5.1. Acute Respiratory Failure
14.5.2. Chronic Obstructive Pulmonary Disease (COPD)
14.5.3. Carbon Monoxide Toxicity
14.5.4. Bronchiectasis
14.5.5. Sleep Apnea
14.5.6. Acute Respiratory Failure
14.5.7. Other Applications
14.6. Middle East & Africa High-flow Nasal Cannula Market Size and Forecast, by Country
14.6.1. GCC Countries
14.6.2. Israel
14.6.3. South Africa
14.6.4. Rest of Middle East & Africa
14.7. Middle East High-flow Nasal Cannula Market Attractiveness Analysis
14.7.1. By Component
14.7.2. By End User
14.7.3. By Applications
14.7.4. By Country
15. Competition Landscape
15.1. Global High-flow Nasal Cannula Market Share Analysis, by Company (2018)
15.2. Company Profiles
15.2.1. Flexicare Medical Limited
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Developments
15.2.1.4. Strategy
15.2.2. Teijin Pharma Limited
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Developments
15.2.2.4. Strategy
15.2.3. Vapotherm
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Developments
15.2.3.4. Strategy
15.2.4. Salter Labs
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Developments
15.2.4.4. Strategy
15.2.5. Teleflex Incorporated
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Developments
15.2.5.4. Strategy
15.2.6. Fisher & Paykel Healthcare Limited
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Developments
15.2.6.4. Strategy
15.2.7. ResMed, Inc.
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Developments
15.2.7.4. Strategy
15.2.8. Smiths Medical
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Developments
15.2.8.4. Strategy
15.2.9. Hamilton Medical
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Developments
15.2.9.4. Strategy
15.2.10. TNI Medical AG
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Developments
15.2.10.4. Strategy
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Our Clients
Fact.MR in Media
Our analysts in Media
High-flow Nasal Cannula Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025